US Stock MarketDetailed Quotes
LCTX Lineage Cell Therapeutics
- 1.020
- -0.100-8.93%
Close Jul 24 16:00 ET
- 1.010
- -0.010-0.98%
Post 16:23 ET
192.60MMarket Cap-7846P/E (TTM)
1.080High1.000Low796.71KVolume1.070Open1.120Pre Close832.48KTurnover0.54%Turnover RatioLossP/E (Static)188.82MShares1.61052wk High2.66P/B149.26MFloat Cap0.83752wk Low--Dividend TTM146.33MShs Float78.000Historical High--Div YieldTTM7.14%Amplitude0.100Historical Low1.044Avg Price1Lot Size
Lineage Cell Therapeutics Stock Forum
Sign in to post a comment
$Lineage Cell Therapeutics(LCTX.US$ reason it is moving up slowly… com/f/176343/x/...
1
$Lineage Cell Therapeutics(LCTX.US$
Lineage Cell Therapeutics Q1 2024 GAAP EPS $(0.04), Inline, Sales $1.444M Beat $1.359M Estimate
Lineage Cell Therapeutics Q1 2024 GAAP EPS $(0.04), Inline, Sales $1.444M Beat $1.359M Estimate
$Lineage Cell Therapeutics(LCTX.US$ Opregen® (Rg6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
Lineage Cell Therapeutics Shares Are Trading Are Higher After the Company Announced 24 Month Visual Acuity Results From Patients Enrolled in a Phase 1/2a Clinical Study of RG6501 in Patients With Geographic Atrophy Secondary to Age-related Macular Degen...
Lineage Cell Therapeutics Shares Are Trading Are Higher After the Company Announced 24 Month Visual Acuity Results From Patients Enrolled in a Phase 1/2a Clinical Study of RG6501 in Patients With Geographic Atrophy Secondary to Age-related Macular Degen...
2
3
#buy 
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Green Dragon 2024OP : Because it’s biotech stock that no one knows about yet